Post-Developmental Function of the RPE-Produced VEGF
Principal Investigator
Yun Le, PhD
University of Oklahoma Health Sciences Center
Oklahoma City, OK, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2008 - May 31, 2010
Grant ID
M2008059
Summary
Vascular endothelial growth factor (VEGF) is a potent growth factor and plays a pivotal role in the pathogenesis of ocular vascular diseases, including wet forms of age-related macular degeneration (AMD). However, VEGF may also be beneficial and is now recognized as a neurotrophic factor. The focus of this study is to determine the function of the VEGF made by a major retinal supporting cell, retinal pigment epithelium (RPE), in photoreceptor survival. It has been suggested that the RPE-derived VEGF may be responsible for the stability and function of the major retinal blood circulation, and abnormality in this circulation will eventually lead to photoreceptor degeneration, a situation similar to that in geographic atrophy (dry AMD). To dissect the function of the RPE-derived VEGF, we have developed a cutting-edge genetic system in mice, which permits the deletion of the VEGF gene specifically in the RPE at a time of our choosing. This unique feature provides an unprecedented advantage over other known genetic systems and allows us to delete the VEGF gene in the mouse RPE after development and investigate the function of the RPE-derived VEGF in adults. The experiments proposed in this application will improve the understanding of the pathophysiology of age-related macular degeneration (AMD). Our results may also be used to develop new therapeutics to prevent vision loss in AMD patients and improve current therapeutics for wet AMD and other ocular vascular diseases. To achieve our goal, we will first delete the VEGF gene in the RPE after development. We will then determine the time course and function of the RPE-derived VEGF in photoreceptor survival with functional and morphological analyses. Finally, we will determine if we can speed up our future studies by applying light-induced oxidative stress and testing its effect on our mouse model.
Related Grants
Macular Degeneration Research
Control of Neovascular AMD by Nuclear Receptor RORalpha
Active Dates
July 01, 2013 - June 30, 2015

Principal Investigator
Jing Chen, PhD
Current Organization
Boston Children’s Hospital, Harvard Medical School
Macular Degeneration Research
The Role of Semaphorin 3E Signaling in Neovascular AMD
Active Dates
July 01, 2013 - August 31, 2015

Principal Investigator
Chenghua Gu, DVM, PhD
Current Organization
Harvard Medical School
Macular Degeneration Research
VEGF-Extracellular Matrix Interactions in Choroidal Neovascularization
Active Dates
July 01, 2012 - October 31, 2014

Principal Investigator
Matthew Nugent, PhD
Current Organization
University of Massachusetts, Lowell